Terms: = Cervical cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Clinical Outcome
7 results:
1. Does the vaginal microbiota play a role in the development of cervical cancer?
Kyrgiou M; Mitra A; Moscicki AB
Transl Res; 2017 Jan; 179():168-182. PubMed ID: 27477083
[TBL] [Abstract] [Full Text] [Related]
2. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.
Alazawi W; Pett M; Strauss S; Moseley R; Gray J; Stanley M; Coleman N
Br J Cancer; 2004 Dec; 91(12):2063-70. PubMed ID: 15545968
[TBL] [Abstract] [Full Text] [Related]
3. Increased incidence of atypical Papanicolaou tests from ThinPreps of postmenopausal women receiving hormone replacement therapy.
Menezes GA; Wakely PE; Stripe DM; Nuovo GJ
Cancer; 2001 Dec; 93(6):357-63. PubMed ID: 11748575
[TBL] [Abstract] [Full Text] [Related]
4. Detection of human papillomavirus in Papanicolaou smears: correlation with pathologic findings and clinical outcome.
Nuovo GJ
Diagn Mol Pathol; 1998 Jun; 7(3):158-63. PubMed ID: 9836071
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of DNA cytometry of postirradiation cervicovaginal smears.
Davey DD; Zaleski S; Sattich M; Gallion H
Cancer; 1998 Feb; 84(1):11-6. PubMed ID: 9500647
[TBL] [Abstract] [Full Text] [Related]
6. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Kurvinen K; Syrjänen K; Syrjänen S
J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
[TBL] [Abstract] [Full Text] [Related]
7. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
[TBL] [Abstract] [Full Text] [Related]
